SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.0001000+899.9%Aug 15 3:35 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Graham Marshman who wrote (516)8/8/1997 12:34:00 PM
From: Scott Pratho   of 1359
 
Personally, I am not as concerned with earnings yet as I am with news regarding citicoline. I see Redux as a steady stream of income that will finance the rest of the pipeline. Citicoline is the drug with blockbuster potential!

Earnings may, however, beat expectations due to the IPIC's stock buyback and maybe a contribution from the fees paid to IPIC from Eli Lilly for the licensing of Prozac for PMS.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext